跳至主要内容
临床试验/NCT02529514
NCT02529514暂停4 期

Usage of Baclofen for Sleep Improvement After Cardiac Surgery

University of Liege1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
暂停
入组人数
30
试验地点
1
主要终点
Polysomnography (quantity & quality of sleep)

研究概览

简要总结

Baclo-Sleep trial aims to investigate the effect of baclofen on sleep after scheduled cardiac surgery.

详细描述

This is a prospective randomized single-blind study involving patients adults admitted to the University Hospital of Liege for a scheduled heart surgery.

The study is based on the oral administration of baclofen (or placebo) the evening Bedrooms (10 pm). This administration begins the day before surgery and ends 5th day after. Sleep is evaluated by various questionnaires at baseline, during the protocol and the end. In addition, a 24 polysomnography is performed the day after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective cardiac surgery

排除标准

  • Haemodynamic instability
  • Psychotic disturbances
  • Acute / Chronic respiratory failure
  • Morbid obesity (BMI > 45 kg/m2)
  • Sleep apnea (treated)
  • Severe hepatic or renal failure
  • Patient refusal

研究组 & 干预措施

Baclofen

Active Comparator

Baclofen 25 mg per os for 7 days at 10 pm every day

干预措施: Baclofen (Drug)

Placebo

Placebo Comparator

Placebo per os for 7 days at 10 pm every day

干预措施: Placebo (Drug)

结局指标

主要结局

Polysomnography (quantity & quality of sleep)

时间窗: Participants will be followed for the duration of hospital stay, an expected average of 10 days

Sleep assessment by polysomnography

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Damien Wertz

MD

University of Liege

研究点 (1)

Loading locations...

相似试验